1Iehnder C,et al. Human recombinant erythrepoiet - in treatment in transfusion dependent anemic patients on maintemance hemodialysis. clin Nephrol, 1989,31:55
3Fisher Jw, et al, Role of erythropoietin and inhibitors of erythropoiesis in the anaemia of renal insuppiciency. Dialysia & Transplan tation, 1987,7:472
4MoriyamaY, James W Effects of testosterone and erythropoietin on erythroid colony formation in human bone marrow cultures. Blood, 1975.45
5Na Jean Y. Androgen therapy in he modialysis patients:kinetic studies of enythropoiesis and red cell survival. Br J Hematol, 1987,67:493
3Eschbach JW.Correction of the anemia of end-stage renal disease with recombinant human erythropoietin:results of a combinant phase Ⅰand Ⅱclinical trial.New Engl J Med,1987;316:73.
4Casati S.et al.Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having hemodialysis.Br Med J,1987;295:1017.
5US rHu Epo Predialysis Study Group.Double-blind.placebocontrolled study of the therapeutic use of rHu Epo for anemia associated with chromic renal failure in predialysis patients.Am J Kidney Dis,1997;18:50.
6Brown CD.et al.Treatment of azotemic,Nonoliguric.anemic patients with human recombinant erythropoietin raises whole viscosity proportioal to hematocrit.Nephron,1991;59:394.
7Lui SF.et al.Once weekly versus twice weekly subcutaneous administration of recombinant human eryhropoietin in patients on continuous ambulatory peritoneal dialysis.Clin Nephrol,1991;36:246.
1Nisli G,Kavakli K,Aydinok Y,et al.Serum erythropoietin levels in patients with beta thalassemia major and intermedia[J].Pediatr Hematol Oncol,1997,14(2):161-167.
2Jelkmann W.Molecular biology of erythropoietin[J].Intern Med,2004,43 (8):649-659.
3Eckardt KU.Erythropoietin:oxygen-dependent control of erythropoiesis and its failure in renal disease[J].Nephron,1994,67 (1):7 -23.
